SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 221 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,410 | -75.4% | 15,001 | -6.2% | 0.00% | – |
| Q2 2023 | $5,728 | +13.7% | 16,001 | +14.3% | 0.00% | – |
| Q1 2023 | $5,040 | +42.2% | 14,001 | +249.9% | 0.00% | – |
| Q4 2022 | $3,545 | -60.6% | 4,001 | -33.3% | 0.00% | – |
| Q3 2022 | $9,000 | -25.0% | 6,001 | 0.0% | 0.00% | – |
| Q2 2022 | $12,000 | -14.3% | 6,001 | 0.0% | 0.00% | – |
| Q1 2022 | $14,000 | -50.0% | 6,001 | 0.0% | 0.00% | – |
| Q4 2021 | $28,000 | -26.3% | 6,001 | +20.0% | 0.00% | – |
| Q3 2021 | $38,000 | -20.8% | 5,001 | 0.0% | 0.00% | – |
| Q2 2021 | $48,000 | +17.1% | 5,001 | 0.0% | 0.00% | – |
| Q1 2021 | $41,000 | +20.6% | 5,001 | 0.0% | 0.00% | – |
| Q4 2020 | $34,000 | -39.3% | 5,001 | 0.0% | 0.00% | -100.0% |
| Q3 2020 | $56,000 | +330.8% | 5,001 | +149.9% | 0.00% | – |
| Q2 2020 | $13,000 | – | 2,001 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,623,533 | $22,851,000 | 6.45% |
| Avoro Capital Advisors LLC | 1,146,579 | $9,987,000 | 3.44% |
| Cormorant Asset Management, LP | 2,095,334 | $18,250,000 | 2.18% |
| Healthcare Value Capital, LLC | 50,000 | $436,000 | 0.72% |
| CAPITAL MANAGEMENT ASSOCIATES /NY/ | 20,000 | $174,000 | 0.25% |
| SABBY MANAGEMENT, LLC | 300,000 | $2,613,000 | 0.14% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 20,398 | $177,000 | 0.10% |
| Granite Investment Partners, LLC | 89,622 | $781,000 | 0.07% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 54,634 | $476,000 | 0.06% |
| Trexquant Investment LP | 67,929 | $592,000 | 0.05% |